Correlation Between Tarsus Pharmaceuticals and LianBio ADR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and LianBio ADR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and LianBio ADR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and LianBio ADR, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and LianBio ADR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of LianBio ADR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and LianBio ADR.

Diversification Opportunities for Tarsus Pharmaceuticals and LianBio ADR

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Tarsus and LianBio is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and LianBio ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LianBio ADR and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with LianBio ADR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LianBio ADR has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and LianBio ADR go up and down completely randomly.

Pair Corralation between Tarsus Pharmaceuticals and LianBio ADR

Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 1.41 times less return on investment than LianBio ADR. But when comparing it to its historical volatility, Tarsus Pharmaceuticals is 1.28 times less risky than LianBio ADR. It trades about 0.08 of its potential returns per unit of risk. LianBio ADR is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest  137.00  in LianBio ADR on August 28, 2024 and sell it today you would earn a total of  81.00  from holding LianBio ADR or generate 59.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy31.72%
ValuesDaily Returns

Tarsus Pharmaceuticals  vs.  LianBio ADR

 Performance 
       Timeline  
Tarsus Pharmaceuticals 

Risk-Adjusted Performance

22 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 22 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
LianBio ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days LianBio ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, LianBio ADR is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Tarsus Pharmaceuticals and LianBio ADR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Tarsus Pharmaceuticals and LianBio ADR

The main advantage of trading using opposite Tarsus Pharmaceuticals and LianBio ADR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, LianBio ADR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LianBio ADR will offset losses from the drop in LianBio ADR's long position.
The idea behind Tarsus Pharmaceuticals and LianBio ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance